Posts by: Jose Lopes

Jose Lopes

September 19, 2017September 19, 2017

Immune System, Nerve Cells Jointly Work to Fight Gut Infections, Suggesting New IBD Treatment Strategies

Nerve cells in the gut work with the immune system to fight infections, suggesting potential therapeutic avenues for inflammatory bowel disease (IBD), say researchers at New York’s Weill Cornell Medicine. ... Read more

September 15, 2017September 15, 2017

Breastfeeding May Protect Babies Against IBD Later in Life, Review Study Finds

News

Breastfeeding newborns and infants can lessen the likelihood that they will develop Crohn’s disease (CD) and ulcerative colitis (UC) later in life, new review study shows. And the longer a ... Read more

July 26, 2017August 18, 2017

Renflexis, a Remicade Biosimilar, Launched in US to Treat Crohn’s and UC

Crohn's Disease, News

New drug Renflexis (infliximab-abda), a therapy for ulcerative colitis and Crohn’s disease, is being launched in the U.S., South Korea’s Samsung Bioepis recently announced. Renflexis is a biosimilar of the ... Read more

July 13, 2017August 29, 2017

Innovate Seeks Orphan Drug Status for Pediatric Ulcerative Colitis Therapy Candidate INN-108

News, Ulcerative colitis

Innovate Biopharmaceuticals recently submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for its potential pediatric ulcerative colitis therapy, INN-108. The FDA issues orphan ... Read more

June 22, 2017June 22, 2017

Glepaglutide Improves Short Bowel Syndrome Patients’ Ability to Get Nutrients from Food, Trial Shows

News

Zealand Pharma‘s glepaglutide (ZP1848) improves short bowel syndrome patients’ ability to absorb nutrients from food, according to a Phase 2 clinical trial. The condition, also known as SBS, occurs ... Read more

May 16, 2017

2 Molecules Identified with Potential Therapeutic Qualities for Chronic Inflammatory Conditions

News

Two molecules with anti-inflammatory qualities have been identified as potential new therapies for chronic conditions such as inflammatory bowel disease (IBD), researchers suggest. The study, “Cheminformatics-aided discovery of small-molecule Protein-Protein ... Read more

May 15, 2017May 15, 2017

Stress Management Could Help Treat Abdominal Pain in IBD Patients, British Study Suggests

News

Managing stress and changing the diets of patients with inflammatory bowel disease (IBD) may help mitigate abdominal pain, a British study suggests. The systematic review, “Interventions for abdominal pain ... Read more

April 19, 2017

Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program

News

Australia’s Immuron announced beneficial results of IMM-124E in acute models of colitis, including clinical parameters, tissue analysis, and immunological biomarkers. Colitis refers mainly to ulcerative colitis and Crohn’s disease, major ... Read more

March 13, 2017March 13, 2017

Baker’s Yeast Worsens Crohn’s Disease, Study Suggests

News

The common yeast strain Saccharomyces cerevisiae, also known as Baker’s yeast, may aggravate Crohn’s disease, research suggests. The study, “A member of the gut mycobiota modulates host purine metabolism ... Read more

March 7, 2017

Epigenetic Enzyme Found Lacking in Some Patients with Crohn’s Disease, Study Suggests

News

Understanding epigenetic mechanisms — changes in gene expression that do not involve changing a gene’s DNA sequence itself — regulating intestinal health may lead to tailored inflammatory bowel disease (IBD) therapies, ... Read more